Inventor · disambiguated record
Yaron Kinar
Also filed as: KINAR YARON
10 granted patents·10 pending applications·21 citations·filing 2008–2022
86Inventor score
Top patents by PatentIndex Score
20 records- 0185US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 0284US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 0381US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 0474US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 0573US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 0673US9474490B2Methods and systems of evaluating a risk of a gastrointestinal cancerMEDIAL RES LTD·Filed 2013·Granted Oct 25, 2016·2 cites·7 claims
- 0769US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 0867US11651189B2Methods and systems of evaluating a risk of a gastrointestinal cancerMEDIAL RES LTD·Filed 2019·Granted May 16, 2023·0 cites·15 claims
- 0966US12020783B2Methods and systems of evaluating a risk of lung cancerMEDIAL RES LTD·Filed 2021·Granted Jun 25, 2024·0 cites·22 claims
- 1063US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 1158US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1257US10452970B2Methods and systems of evaluating a risk of a gastrointestinal cancerMEDIAL RES LTD·Filed 2016·Granted Oct 22, 2019·0 cites·15 claims
- 1357US2011052501A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsDASSA LIAT·Filed 2009·Application pending·0 cites
- 1456US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 1555US11031105B2Methods and systems of evaluating a risk of lung cancerMEDIAL RES LTD·Filed 2014·Granted Jun 8, 2021·0 cites·20 claims
- 1655US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1752US2016177395A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1851US2024161005A1Add-on to a machine learning model for interpretation thereofMEDIAL EARLYSIGN LTD·Filed 2022·Application pending·0 cites
- 1949US2013315819A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 2044US2011003708A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →